Michael T. Heneka

Active 1998–2026

248
Papers
51,162
Citations
110
h-index
231
i10-index

Citations

Citations per year for Michael T. Heneka1971: 1 citations1992: 7 citations1999: 12 citations2000: 22 citations2001: 50 citations2002: 56 citations2003: 74 citations2004: 88 citations2005: 123 citations2006: 203 citations2007: 227 citations2008: 260 citations2009: 199 citations2010: 238 citations2011: 231 citations2012: 352 citations2013: 366 citations2014: 451 citations2015: 565 citations2016: 634 citations2017: 758 citations2018: 812 citations2019: 2,073 citations2020: 2,589 citations2021: 2,916 citations2022: 2,708 citations2023: 2,363 citations2024: 3,324 citations2025: 2,046 citations2026: 60 citations1972–1991: no citations, so these years are not shown1993–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,764 citing papers, 21.4% of this breakdownChina: 3,859 citing papers, 14.4% of this breakdownGermany: 1,791 citing papers, 6.7% of this breakdownUnited Kingdom: 1,707 citing papers, 6.4% of this breakdownItaly: 1,164 citing papers, 4.3% of this breakdownSpain: 925 citing papers, 3.4% of this breakdownCanada: 857 citing papers, 3.2% of this breakdownFrance: 809 citing papers, 3% of this breakdownSweden: 697 citing papers, 2.6% of this breakdownAustralia: 692 citing papers, 2.6% of this breakdownIndia: 667 citing papers, 2.5% of this breakdownSouth Korea: 600 citing papers, 2.2% of this breakdown
0%21.4%Other 27.3%

Fields

  • Medicine42.6%
  • Neuroscience28.2%
  • Biochemistry, Genetics and Molecular Biology20.8%
  • Immunology and Microbiology3.1%
  • Nursing0.9%
  • Agricultural and Biological Sciences0.6%
  • Other3.8%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms11.8%
  • Alzheimer's disease research and treatments11.6%
  • Tryptophan and brain disorders4.2%
  • Dementia and Cognitive Impairment Research3%
  • Inflammasome and immune disorders2.6%
  • Neurological Disease Mechanisms and Treatments1.7%
  • Other65.1%

Coauthors

All papers

Open in search
  1. Neuroinflammation in Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Olga Garaschuk, Erik Boddeke, Charles A. Dinarello, John C.S. Breitner, Greg M. Cole, Douglas T. Golenbock, Markus P. Kummer - The Lancet Neurology 2015 cited by 6,102

  2. Microglia states and nomenclature: A field at its crossroads

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ukpong B. Eyo, Elena Galea, Sonia Garel, Florent Ginhoux, Christopher K. Glass, Özgün Gökçe, Diego Gómez‐Nicola, Berta González, Siamon Gordon, Manuel B. Graeber, Andrew D. Greenhalgh, Pierre Gressèns, Melanie Greter, David H. Gutmann, Christian Haass, Michael T. Heneka, Frank L. Heppner, Soyon Hong, David Hume, Steffen Jung, Helmut Kettenmann, Jonathan Kipnis, Ryuta Koyama, Greg Lemke, Marina A. Lynch, Ania K. Majewska, Marzia Malcangio, Tarja Malm, Renzo Mancuso, Takahiro Masuda, Michela Matteoli, Barry W. McColl, Véronique E. Miron, Anna V. Molofsky, Michelle Monje, Éva Mracskó, Agnès Nadjar, Jonas J. Neher, Urtė Neniškytė, Harald Neumann, Mami Noda, Bo Peng, Francesca Peri, V. Hugh Perry, Phillip G. Popovich, Clare Pridans, Josef Priller, Marco Prinz, Davide Ragozzino, Richard M. Ransohoff, Michael W. Salter, Anne Schaefer, Dorothy P. Schafer, Michal Schwartz, Mikael Simons, Cody J. Smith, Wolfgang J. Streit, Tuan Leng Tay, Li‐Huei Tsai, Alexei Verkhratsky, Rommy von Bernhardi, Hiroaki Wake, Valérie Wittamer, Susanne A. Wolf, Long‐Jun Wu, Tony Wyss‐Coray - Neuron 2022 cited by 1,880

  3. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice

    Authors: , , , , , , , , , , , , , , - Nature 2012 cited by 2,923

  4. NLRP3 inflammasome activation drives tau pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 1,559

  5. Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , - Nature 2017 cited by 1,006

  6. Inflammasome signalling in brain function and neurodegenerative disease

    Authors: , , - Nature reviews. Neuroscience 2018 cited by 825

  7. Innate immune activation in neurodegenerative disease

    Authors: , , - Nature reviews. Immunology 2014 cited by 1,434

  8. Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus

    Authors: , , , - Nature Reviews Neurology 2021 cited by 411

  9. A guiding map for inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank L. van de Veerdonk, Charles A. Dinarello - Nature Immunology 2017 cited by 823

  10. Microglia in Alzheimer’s disease

    Authors: , - Journal of Clinical Investigation 2017 cited by 942

  11. Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes

    Authors: , , , , , , , , , , , , , , - Cell 2021 cited by 355

  12. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Hardy, Marco Colonna, Christian Haass - Science Translational Medicine 2014 cited by 837

  13. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ann D. Cohen, Alisha Daniels, Marion Delarue, Mira Didic, Alexander Drzezga, Bruno Dubois, Marie Eckerström, Laura L. Ekblad, Sebastiaan Engelborghs, Stéphane Epelbaum, Anne M. Fagan, Yong Fan, Tormod Fladby, Adam Fleisher, Wiesje M. van der Flier, Stefan Förster, Juan Fortea, Kristian Steen Frederiksen, Yvonne Freund‐Levi, Lars Frings, Giovanni B. Frisoni, Lutz Fröhlich, Tomasz Gabryelewicz, Hermann‐Josef Gertz, Kiran Dip Gill, Olymbia Gkatzima, Estrella Gómez‐Tortosa, Timo Grimmer, Eric Guedj, Christian Habeck, Harald Hampel, Ron Handels, Oskar Hansson, Lucrezia Hausner, Sabine Hellwig, Michael T. Heneka, Sanna‐Kaisa Herukka, Helmut Hildebrandt, John R. Hodges, Jakub Hort, Chin‐Chang Huang, Ane Iriondo, Yoshiaki Itoh, Adrian Ivanoiu, William J. Jagust, Frank Jessen, Peter Johannsen, Keith A. Johnson, Ramesh Kandimalla, Elisabeth Kapaki, Silke Kern, Lena Kilander, Aleksandra Klimkowicz‐Mrowiec, William E. Klunk, Norman Koglin, Johannes Kornhuber, Milica G. Kramberger, Hung‐Chou Kuo, Koen Van Laere, Susan Landau, Brigitte Landeau, Dong Young Lee, Mony J. de Leon, Cristian E. Leyton, Kun‐Ju Lin, Alberto Lleó, Malin Löwenmark, Karine Madsen, Wolfgang Maier, Jan Marcusson and 83 more - JAMA Neurology 2022 cited by 288

  14. Innate immunity in Alzheimer's disease

    Authors: , , - Nature Immunology 2015 cited by 900

  15. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Niels Hansen, Mathias Bähr, Inga Zerr, Agnes Flöel, Peter J. Nestor, Emrah Düzel, Wenzel Glanz, Enise I. Incesoy, Katharina Bürger, Daniel Janowitz, Robert Perneczky, Boris‐Stephan Rauchmann, Franziska Hopfner, Olivia Wagemann, Johannes Levin, Stefan Teipel, Ingo Kilimann, Doreen Göerß, Johannes Prudlo, Thomas Gasser, Kathrin Brockmann, David Mengel, Milan Zimmermann, Matthis Synofzik, Carlo Wilke, Judit Selma‐González, Janina Turón‐Sans, Miguel Santos‐Santos, Daniel Alcolea, Sara Rubio‐Guerra, Juan Fortea, Álvaro Carbayo, Alberto Lleó, Ricardo Rojas‐García, Ignacio Illán‐Gala, Michael Wagner, Ingo Frommann, Sandra Roeske, L Bertram, Michael T. Heneka, Frederic Brosseron, Alfredo Ramı́rez, Matthias Schmid, Rudi Beschorner, Annett Halle, Jochen Herms, Manuela Neumann, Nicolas R. Barthélemy, Randall J. Bateman, Patrizia Rizzu, Peter Heutink, Oriol Dols‐Icardo, Günter U. Höglinger, Andreas Hermann, Anja Schneider - Nature Medicine 2024 cited by 185

  16. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - EMBO Molecular Medicine 2016 cited by 530

  17. CD8+ T-cells infiltrate Alzheimer’s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice

    Authors: , , , , , , , , , , - Brain Behavior and Immunity 2020 cited by 253

  18. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease

    Authors: , , - Immunology and Cell Biology 2019 cited by 375

  19. Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Neuron 2024 cited by 171

  20. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Alzheimer s Research & Therapy 2018 cited by 257

  21. The role of peripheral inflammatory insults in Alzheimer’s disease: a review and research roadmap

    Authors: , , , , , - Molecular Neurodegeneration 2023 cited by 106

  22. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia

    Authors: , , , , , , , , - Journal of Neurochemistry 2019 cited by 185

  23. TLR2 Is a Primary Receptor for Alzheimer’s Amyloid β Peptide To Trigger Neuroinflammatory Activation

    Authors: , , , , , , , , , , , - The Journal of Immunology 2011 cited by 440

  24. Cerebral dysfunctions caused by sepsis during ageing

    Authors: , - Nature reviews. Immunology 2021 cited by 189